Prognostic Value of Radiomic Features of (18)F-FDG PET/CT in Patients With B-Cell Lymphoma Treated With CD19/CD22 Dual-Targeted Chimeric Antigen Receptor T Cells

OBJECTIVE: In the present study, we aimed to evaluate the prognostic value of PET/CT-derived radiomic features for patients with B-cell lymphoma (BCL), who were treated with CD19/CD22 dual-targeted chimeric antigen receptor (CAR) T cells. Moreover, we explored the relationship between baseline radio...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yeye, Li, Jihui, Zhang, Xiaoyi, Jia, Tongtong, Zhang, Bin, Dai, Na, Sang, Shibiao, Deng, Shengming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858981/
https://www.ncbi.nlm.nih.gov/pubmed/35198451
http://dx.doi.org/10.3389/fonc.2022.834288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858981/
https://www.ncbi.nlm.nih.gov/pubmed/35198451
http://dx.doi.org/10.3389/fonc.2022.834288

Ejemplares similares